(Q36417740)

14 August 2017

1 reference

title

Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing? (English)

1 reference

14 August 2017

1 reference

Susan F Slovin

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

14 August 2017

published in

Nature Reviews Urology

1 reference

14 August 2017

volume

3

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

138-144

1 reference

Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

Chemotherapy for Small Cell Carcinoma of Prostatic Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Small Cell Anaplastic Carcinoma of the Prostate: A Clinical, Pathological and Immunohistological Study of 27 Patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Argentaffin cells in prostatic carcinoma: differentiation from lipofuscin and melanin in prostatic epithelium

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

The histogenesis of small cell carcinoma of the prostate an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Biological selection criteria for radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Inhibitory effect of IL-6-induced neuroendocrine cells on prostate cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Neuroendocrine cells in peripheral prostatic zone: age, prostatic intraepithelial neoplasia and latent cancer-related changes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Neuroendocrine cells in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Serum chromogranin A: early detection of hormonal resistance in prostate cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Clinical significance of elevated serum chromogranin A levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Metastatic pure small-cell carcinoma of prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Small cell carcinoma of prostate: Effectiveness of hormonal versus chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

PET in the diagnosis of neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Small cell and anaplastic prostate cancer: correlation between CT findings and prostate-specific antigen level

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Why we must better understand neuroendocrine differentiation in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0435

7 January 2021

Identifiers

DOI

10.1038/NCPURO0435

1 reference

14 August 2017

1 reference